Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 05 02:19PM ET
3.00
Dollar change
-0.42
Percentage change
-12.28
%
Index- P/E- EPS (ttm)-2.22 Insider Own71.43% Shs Outstand13.40M Perf Week-24.43%
Market Cap40.20M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float3.83M Perf Month-49.66%
Income-30.37M PEG- EPS next Q- Inst Own2.50% Short Float1.17% Perf Quarter-53.85%
Sales21.27M P/S1.89 EPS this Y- Inst Trans- Short Ratio1.41 Perf Half Y-18.48%
Book/sh1.18 P/B2.54 EPS next Y- ROA-43.41% Short Interest0.04M Perf Year-49.66%
Cash/sh1.55 P/C1.93 EPS next 5Y- ROE-136.05% 52W Range2.05 - 8.48 Perf YTD-58.10%
Dividend Est.- P/FCF- EPS past 5Y9.04% ROI-86.91% 52W High-64.62% Beta0.55
Dividend TTM- Quick Ratio2.32 Sales past 5Y75.81% Gross Margin55.18% 52W Low46.34% ATR (14)0.49
Dividend Ex-Date- Current Ratio3.20 EPS Y/Y TTM26.30% Oper. Margin-174.19% RSI (14)20.69 Volatility11.82% 10.24%
Employees243 Debt/Eq1.21 Sales Y/Y TTM-42.92% Profit Margin-142.77% Recom1.00 Target Price6.00
Option/ShortYes / Yes LT Debt/Eq1.21 EPS Q/Q-58.41% Payout- Rel Volume2.60 Prev Close3.42
Sales Surprise- EPS Surprise- Sales Q/Q-11.82% EarningsNov 15 BMO Avg Volume31.86K Price3.00
SMA20-37.34% SMA50-44.39% SMA200-38.41% Trades Volume62,405 Change-12.28%
Date Action Analyst Rating Change Price Target Change
May-18-21Initiated BTIG Research Buy $4
Apr-26-21Initiated Mizuho Buy $3.80
Oct-23-20Initiated Oppenheimer Outperform $5
Sep-22-16Initiated Maxim Group Buy $4
Oct-29-15Resumed H.C. Wainwright Buy $2.50 → $3
Jun-23-15Initiated H.C. Wainwright Buy $2.50
Nov-15-24 08:00AM
Nov-13-24 07:29AM
Oct-24-24 08:00AM
Sep-04-24 08:00AM
Aug-16-24 08:00AM
03:04PM Loading…
Jul-29-24 03:04PM
Jul-19-24 05:30PM
Jul-08-24 07:30AM
Jun-27-24 09:42AM
07:34AM
Jun-26-24 04:15PM
04:10PM
May-15-24 11:04AM
08:00AM
May-14-24 01:54PM
08:00AM Loading…
08:00AM
Apr-08-24 05:00PM
Mar-28-24 12:53PM
07:00AM
Mar-05-24 07:00AM
Feb-16-24 07:00AM
Nov-14-23 07:00AM
Nov-08-23 07:00AM
Aug-11-23 07:00AM
Aug-01-23 07:00AM
Jul-20-23 08:00AM
May-28-23 08:35AM
May-17-23 07:35AM
Apr-26-23 09:35AM
07:00AM
07:11AM Loading…
Apr-17-23 07:11AM
Mar-21-23 04:30PM
Feb-06-23 08:07AM
Jan-06-23 08:42AM
07:00AM
Dec-15-22 07:00AM
Nov-17-22 05:39AM
Nov-14-22 08:15AM
07:00AM
Sep-23-22 07:00AM
Sep-07-22 07:00AM
Aug-12-22 08:35AM
07:00AM
06:25AM
Aug-05-22 08:38AM
Jul-08-22 07:00AM
Jun-02-22 06:34AM
May-26-22 04:30PM
May-25-22 07:53AM
May-24-22 07:00AM
May-12-22 08:15AM
07:00AM
May-10-22 09:25AM
May-02-22 10:15AM
07:00AM
Apr-01-22 07:27AM
07:00AM
Mar-31-22 07:15PM
04:54AM
Mar-28-22 07:00AM
Mar-23-22 07:00AM
Mar-04-22 07:00AM
Feb-23-22 04:36AM
Feb-16-22 07:00AM
Feb-15-22 05:03PM
Jan-20-22 08:50AM
07:00AM
Jan-18-22 07:00AM
Jan-09-22 07:28AM
Jan-03-22 07:00AM
Dec-17-21 07:00AM
Dec-10-21 07:15AM
07:00AM
Nov-25-21 04:34AM
Nov-22-21 07:17AM
Nov-15-21 07:00AM
Nov-12-21 07:00AM
Nov-05-21 07:00AM
Nov-02-21 07:00AM
Nov-01-21 03:01PM
Oct-25-21 07:50AM
07:00AM
Oct-06-21 07:17AM
Sep-27-21 02:01PM
Sep-20-21 07:00AM
Aug-23-21 09:58AM
07:00AM
Aug-14-21 03:10AM
Aug-12-21 10:05AM
07:00AM
Aug-10-21 07:00AM
Aug-02-21 03:01PM
Jul-25-21 03:49AM
Jun-10-21 07:00AM
02:06AM
May-27-21 07:00AM
May-17-21 10:20AM
May-13-21 07:00AM
05:45AM
May-11-21 07:00AM
CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing innovative therapeutics and pharmaceutical products. The firm is also involved in developing innovative therapeutics addressing cancer and other unmet medical needs for the global market. The company was founded in 1991 and is headquartered in Beijing, China.